drugset / Trial / NCT01826786

The Effects of JNJ-42165279 on the Neural Basis of Anxiety Disorders in Healthy Male Volunteers

NCT01826786 ↗

Phase 1 Completed 43 enrolled Janssen Research & Development, LLC
RandomizedParallel-groupDouble-blindBasic science

Summary

The purpose of this study is to evaluate the potential efficacy of JNJ-42165279 in treating anxiety disorders through evaluation of brain activation patterns using imaging technology in healthy volunteers.

Timeline

Start
2013-08
Primary completion
2014-08
Completion
2014-08

Drugs

EvaluationDrugModalityDoseRoute
Subject JNJ-42165279 Small molecule 100 mg Oral

Indications

No indication recorded.